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Abstract
Background: In 2008 a clinical transition pathway for young people with juvenile-onset rheumatic and
musculoskeletal diseases (jRMD) aiming at improving transitional care was instituted. Historical data on drop-out
rate in our clinic was 35%, one year before the implementation of the transition pathway. This study aims to I)
evaluate the effectiveness of the clinical transition pathway, II) evaluate the experiences and satisfaction of YP with
the transitional process and evaluate their perceived self-management skills.
Methods: Young people with any jRMD transferred from the pediatric to the adult rheumatology department in
our academic center were eligible to enroll in this quantitative cross-sectional observational study between 2009
and 2015. Notably in 2012, we created a dedicated adolescent JIA-clinic, located at the adult rheumatology
department. Electronic patient records from all young people that were transferred between 2009 and 2015 were
reviewed for drop-out of care. Young people were asked to rate a VAS for ‘satisfaction with transition’ and to
complete the “on your own feet transfer experience scale” (OYOF-TES)-questionnaire regarding their experiences
and satisfaction with transition. Self-management skills were measured with the “on your own feet self-efficacy
scale” (OYOF-SES)-questionnaire.
Results: One hundred fifty-four young people were transferred to the adult department, of which 76 were
transferred to the dedicated adolescent JIA-clinic. The mean age at transfer was 17.8 years for YP transferred to the
adult clinic and 15.2 years for transfer to the adolescent clinic. Drop-out of care rate one year after transfer was 5.
1% in the adult clinic and 1.3% in the adolescent JIA-clinic. Response rate of the returned questionnaires was 61%
for the adolescent JIA clinic and 36% for the adult clinic. There was no difference between responders and non-
responders in demographics and disease type besides age (non-responders were significantly younger). Young
people transferred to the adult and adolescent JIA-clinic both had high scores on the satisfaction scale (7.7 and 7.5
on the VAS-scale and 72.0 and 74.5 on the OYOF-TES). Self-efficacy scores were high for both groups, with OYOF-
SES 59.7 for those transferred to the adult clinic and 58.2 for those transferred to the adolescent JIA-clinic.
Conclusion: The implementation of the clinical transition pathway has led to a substantial improvement of patient
care during the transitional process leading to low drop-out of care rate and high scores on satisfaction with
transition. High scores on the self-reported self-efficacy scale suggests confidence of young people to have
achieved sufficient skills to successfully manage their disease.
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Background
It is generally accepted that young people (YP) with
juvenile-onset rheumatic and musculoskeletal diseases
(jRMD) need to be prepared well in advance, to
achieve a successful transfer to adult rheumatology
care [1–5]. Well-coordinated and effective manage-
ment of the transitional process during adolescence is
necessary to enable YP to acquire sufficient skills to
independently manage their disease. Previously, we
found that YP with jRMD who attended the pediatric
rheumatology service before a dedicated transition
program was established, were dissatisfied with the prep-
aration for transfer to adult care [6]. The central points of
YP in this study were that i) training self-management
skills was neglected, ii) specific topics like education, voca-
tion as well as the upcoming transfer to adult care were
not discussed in clinic and iii) they didn’t feel confident to
attend the consultation without the support of their par-
ents [6]. These findings are in line with results from other
studies where ad hoc, unprepared transfer to adult care
carried a high risk for lack of self-management skills and
independence of YP, missed appointments and drop-out
of care, non-compliance with medication and ultimately
poor disease outcome [7–9].
Transition of care is a complex intervention, only few
studies are available regarding the evaluation of the transi-
tional process and there is a lack of clarity regarding which
outcomes are relevant to determine the success of the
transitional process. Drop-out of care rates are used as
outcome measure for successful transition, being between
25 and 52% even after implementation of a transition pro-
gram [10–13]. Other outcomes used are the satisfaction of
YP with the transitional process and development of
self-management skills [5, 14, 15]. Several studies also
used physical, psychosocial and rheumatic specific health
status as outcome measure for the success of implement-
ing a transition program [11, 16–19]. However, there is no
gold standard for successful transition [1, 5, 15, 18, 20].
Additionally, it is also unclear as to whose perception the
success should be measured -success as perceived by the
young person and/or parent and/or professional - and at
which time point success of transition should be mea-
sured. These questions continue to be debated and are an
area for further research.
Recently, EULAR/PReS endorsed recommendations
for transitional care were published that include the
definition of specific outcomes that can be used in fu-
ture to measure successful transition to adult care [5].
Outcomes can be categorized in the area of health ser-
vice outcomes (e.g attending medical appointments/
drop-out, patients first visit no later than 3–6 months
after transfer), individual outcomes (e.g self-management,
adherence, quality of life, satisfaction with transition), so-
cial outcomes (having a social network) and alignment
(assuring a good coordination and collaboration between
pediatric and adult health care professionals) [1, 15].
The aims of the present study were I) to evaluate the ef-
fectiveness of a clinical transition pathway implemented in
our institution since 2008 II) to evaluate the experiences
and satisfaction of YP with jRMD with the transitional
process III) to evaluate the perceived self-management
skills of YP with jRMD.
Methods
Participants and study design
A quantitative cross-sectional observational study in a
real life setting was conducted. All YP with any jRMD
who were transferred from the pediatric to the adult
rheumatology clinic between 2009 and 2015 in our
academic hospital were eligible to enroll in this study.
Notably, all patients preferred to continue care in our
center after transfer, none transferred to another medical
center due to 1) our active policy to advocate continuing
care in the same center, 2) the expertise with adolescent
care in our center and 3) the limited travel distances in
our country. Patients with the subtype oligo-articular
JIA with medication-free disease remission for ≥ one
year before transfer, were not included as it is our policy
to routinely discharge these patients from clinical care.
All YP and their parents (if age < 18 years) gave written
informed consent before inclusion.
Clinical transition pathway
The clinical transition pathway was described previously
[6]. The most important points of this clinical transition
pathway are an early start (12–14 years) with focus on
development of self-management skills and indepen-
dency using an individual transition plan (ITP) for each
patient and his/her parents [6]. The ITP developed by
McDonagh et al. (2006, 2015) was adjusted for this
purpose [21, 22]. The ITP is an important tool for
developing self-management skills and self-efficacy with
attention for the entire transitional process (Additional
file 1: Table S1).
During the study inclusion period (2009–2015), we
created a dedicated adolescent JIA-clinic in 2012 at the
adult rheumatology department. This was primarily
developed for YP with JIA in the age of 12–23 years to
optimally support the specific needs of adolescents and
the transitional process (Additional file 2: Figure S1:
clinical transition pathway, adjusted from [6]). In addition,
patients with other (rare) diseases that were only seen by
the rheumatologist were also transferred to the dedi-
cated JIA-adolescent clinic. The adolescent JIA-clinic
health care team consists of a mixture of paediatric and
adult-care health professionals including (pediatric) rheu-
matologists, pediatric physiotherapists, specialized rheuma-
tology nurses and nurse practitioners with certified training
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in pediatrics. The actual transfer to the adolescent
JIA-clinic is between 12 and 14 years. The time of
transfer is a joint decision by the patient and physician.
Clinical care for YP with systemic autoimmune diseases
after 2012 continued to be delivered at the pediatric
rheumatology department in the children’s hospital, due
to the necessity of involvement of other pediatric subspe-
cialties (e.g.pediatric neurology, hematology, nephrology).
Actual transfer to the adult clinic occurred around the age
of 17–18 years, where timing of the transfer depends on
the patient’s achieved skills, personal wishes in discussion
with health professionals (Additional file 3: Figure S2: clin-
ical transition pathway as published previously [6]).
Data collection
To evaluate effectiveness, electronic patient records (n =
154) were reviewed on frequency of drop-out of care and
the use of ITPs. YP were asked at study inclusion to
complete a questionnaire that inventoried their experi-
ences and satisfaction with the transitional process. They
received the questionnaire once, a reminder by letter was
sent after two weeks. The questionnaire included the fol-
lowing topics: demographic parameters, age, ethnicity,
education, vocation, self-efficacy, self-management and
satisfaction with transition.
Outcome measurements
Primary outcomes
The primary outcomes in this study were drop-out of care
at one, two and three years after transfer and satisfaction
with the transitional process. Drop-out was defined as YP
who did not attend any follow up appointment at the ded-
icated adolescent JIA/adult clinic one year after the last
appointment in the pediatric clinic.
Satisfaction with transition was measured by the “on
your own feet transfer experience scale” (OYOF-TES) and
a visual analogue scale assessing satisfaction with transi-
tion [10]. The OYOF-TES is a validated eighteen item pa-
tient reported outcome that measures experiences in
transition, rated on five-point Likert scales (1 = strongly
disagree to 5 = strongly agree) [10]. Seven items reflect the
preparation for transition and eleven items reflect the
alignment and collaboration between the pediatric and
adult care [10]. A higher score on the OYOF-TES (score
range 18–90) expresses higher experienced satisfaction of
the YP with the transitional process, a specific cut-off
point is not defined [10].
The VAS is a one-dimensional question asking: How
satisfied were you with the overall process of transfer to
the adolescent JIA/adult clinic on a Likert scale ranging
from 1 to 10 (1 = completely unsatisfied to 10 = completely
satisfied) [10].
Secondary outcomes
Secondary outcomes were independent visits of YP
with the nurse and physicians defined as a visit without
their parents being present for the whole visit, the
number of ITP’s present at transfer, self-management
skills and the self-efficacy of the YP. To measure the ef-
ficacy of the implemented clinical transition pathway,
the number of adolescents with an ITP were collected
from the electronic patient records. Self-efficacy is
measured with the on your own feet self-efficacy scale
(OYOF-SES) [23]. This self-reported questionnaire con-
sists of 17 items with a Likert scale from 1 to 4
(ranging from 1 = no, certainly not- 4 = yes, certainly).
Four items reflect self-efficacy coping with the condi-
tion, six items reflect self-efficacy in disease-knowledge
and six items reflect self-efficacy in skills for independ-
ent behavior. A higher score on the OYOF-SES (score
range 10–64) expresses the perception of YP to have
more self-reliance to manage the disease by themselves
[23]. We asked YP an additional eight questions reflecting
self-management skills. These questions were copied from
a previous study [6] (Additional file 4: Table S2). Further-
more, we asked YP three additional questions regarding
whether their disease had affected their educational
achievements and whether the disease had affected their
career choice.
Statistical analysis
We used descriptive statistics to describe the study sample
by using STATA14. For continuous variables, the mean
and standard deviation (SD) are shown, for categorical
data percentages were presented. To compare the group
of questionnaire responders and non-responders and the
differences between YP transferred to the adolescents JIA
clinic or adult clinic unpaired t-test or Wilcoxon’s rank
sum test, if data were not normally distributed, were
used. Categorical variables were tested using Pear-son’s
chi-square test. P-value < 0.05 was considered statisti-
cally significant. Data from YP with JIA who were
transferred to the dedicated adolescent JIA clinic and
those transferred to the adult clinic, were separately
analyzed.
Results
All electronic patient records of YP with jRMD who
were transferred from the pediatric to the adult rheuma-
tology department between 2009 and 2015 were
reviewed (n = 154). In total 78 YP were transferred to
the adult clinic and 76 to the dedicated adolescent
JIA-clinic. Demographics and disease activity of all YP
who were transferred are shown in Table 1. As expected
the mean age at study inclusion of the YP transferred to
the adult clinic was higher when compared with the YP
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transferred to the dedicated adolescent JIA-clinic. The
majority of all study patients had oligo-articular or
poly-articular JIA.
Results electronic patient records
The overall frequency of ‘drop-out of care’ one year after
transfer to the adult clinic was low, with only 5.1% of YP
that did not attend any clinical appointment within the
first year after transfer. The drop-out of care frequency
remained stable in the next two years after transfer to
the adult rheumatology team (Table 2).
This percentage of drop-out of care was 1.3% for YP
who were transferred to the dedicated adolescent-JIA
clinic one year after transfer. The drop-out of care
frequency of YP transferred to the adolescent JIA-clinic
decreased to zero after three years (Table 2).
Almost all YP (94%) were transferred to the dedi-
cated adolescent JIA-clinic with an ITP. This was in
contrast to 55% ITPs in the group of YP who had
been transferred to the adult clinic. This reflects the
‘real life study’ setting of this study, the frequency of
not only discussing the ITP but also filing the results
in the ITP became more and more incorporated in
clinical care during the inclusion period of the study.
This is reflected by the higher number of ITPs in the
adolescent JIA clinic, as this study group primarily in-
cludes patients in a later time period of inclusion
(2012–2015).
Table 1 Demographics of YP transferred from pediatric rheumatology to the adult rheumatology clinic and the adolescent JIA-clinic
between 2009 and 2015
YP transferred to the adult clinic (n = 78) YP transferred to the adolescent JIA-clinic (n = 76)
Transfer period 2009–2015 2012–2015
Gender Female (%) 71% 56%
Mean age (SD) at time of study inclusion 22.2 (2.4) 18.6 (2.3)
Mean age (SD) at transfer 17.8 (1.5) 15.2 (2.1)
Diagnosis (n / %)
• JIA – oligoarticular • 21 / 27 • 26 / 37
• JIA – polyarticular • 15 / 19 • 21 /30
• JIA – PSA • 3 / 4 • 3 /4
• JIA – ERA • 8 / 10 • 7 /10
• SLE • 15 / 19 • 1 /2
• Other (e.g. GPA, FMF) • 16 / 21 • 12 /17
Disease activity before transfer (median, IQR)
• Number of tender joints • 0 (0–0) • 0 (0–0)
• Number of swollen joints • 0 (0–0) • 0 (0–0)
• ESR • 8 (3–17) • 8 (3–15)
Disease activity after transfer
(median, IQR)
• Number of tender joints • 0.(0–0) • 0 (0–1)
• Number of swollen joints • 0.(0–0) • 0 (0–1)
• ESR • 9 (4–19) • 8 (3–15)
Abbreviations: JIA Juvenile Idiopathic Arthritis, PsA Psoriatic Arthritis, ERA Enthesitis Related Arthritis, SLE Systemic Lupus Erythematosus, GPA Granulomatosis with
Polyangiitis, FMF Familial Mediterranean Fever
Table 2 Drop-out rate of YP and the presence ITP after transfer to adult rheumatology clinic and adolescent JIA clinic
YP transferred to the adult clinic
N = 78
YP transferred to the adolescent JIA clinic
N = 76
p-value
Drop-out rate after 1 year (% / N) 5.1% (4 of 78) 1.3% (1 of 76) 0.18
Drop-out rate after 2 years (% / N) 6.7% (5 of 74) # 2.7% (2 of 75) 0.51
Drop-out rate after 3 years (% / N) 5.7% (4 of 69) # 0% (0 of 73) 0.10
Total drop-out rate (1–3 years after transfer) 16.6% (13 of 78) 3.9% (3 of 76)
Presence of ITP at transfer (%) 55% 94% < 0.01*
Abbreviations: YP Young People, JIA Juvenile Idiopathic Arthritis *: P-value < 0.05 was considered statically significant #: drop-out rate for year 2 and year 3: the
number of remaining patients in care were taken as the total number of patients in that year of follow up
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Results questionnaires
In total 46/76 YP transferred to the adolescent
JIA-clinic and 28/78 YP transferred to the adult clinic
returned questionnaires, leading to a response rate of
respectively 61 and 36%. There were no differences
between questionnaire-responders and non-responders
regarding demographics or disease-type besides age
(non-responders were younger 19.7 versus 21.4 years, p =
< 0.001). Not surprisingly, the drop-out of care in the
non-responders was higher (total number of drop-outs
in non-responders n = 5/80 and in responders n = 0/74,
p = 0.02). The mean age of the responders at the time
of study inclusion was 18.4 years (SD 2.8) for the dedi-
cated adolescent JIA-clinic and 21.46 years (SD 2.5) for
the YP transferred to the adult clinic.
The satisfaction with the transitional process for both
scales (OYOF-TES and VAS transition) of YP who either
transferred to the adult clinic or to the dedicated adolescent
JIA-clinic was high (Table 3). The questions regarding the
alignment and collaboration between pediatric and adult
health care resulted in high scores for both groups [10];
about 80% thought their new care provider was well in-
formed about the condition of the YP and their treatment.
Furthermore, 78.6% of the YP transferred to the adult clinic
and 80% transferred to the adolescent JIA-clinic were con-
vinced that there was a good collaboration between
pediatric and adult care.
Self-management, measured with the OYOF-SES, was
high in both groups (Table 3). More positive responses
to the eight self-reported questions measuring self-
management skills (e.g. independently visiting the nurse
or physicians, ordering medication and making appoint-
ments independently) were seen in the group transferred
to the adult clinic (Table 3). Furthermore, almost all YP in
both transfer groups agreed that all important topics were
discussed during the consultations. The transfer was dis-
cussed on time according to the YP in more than three
quarters for both groups.
The answers to the three questions regarding educa-
tion and vocation showed that the majority of all YP
Table 3 Questionnaire results of YP transferred to the adult or adolescent JIA-clinic
Questionnaires Responders transferred to
the adult clinic N = 28
Responders transferred to the
adolescent JIA clinic N = 46
p-value
VAS satisfaction with transition ± (mean, SD) 7.7 (0.8) 7.5 (1.9) 0.79
OYOF-TES ± ± (mean, SD) 72.0 (14.7) 74.5 (12.1) 0.44
Treatment recommendations in the adult care setting are similar
to those I used to receive in pediatric care (agreed,%)
85.7 79.5 0.51
There was good collaboration between pediatric and adult care
(agreed,%)
78.6 80 0.88
OYOF-SES ± ± ± (mean, SD) 59.7 (2.9) 58.2 (5.0) 0.42
Independent visits physician (yes) 69% 47% 0.06
Independent visits nurse (yes) 75% 44% 0.01*
Important topics discussed (yes) 97% 96% 0.83
I order my medication at the pharmacy by myself (yes) 83% 52% 0.008*
Thinking about taking medication by myself (yes) 90% 80% 0.27
Forgetting medication (yes) 52% 80% 0.01*
Making appointments independently (yes) 86% 42% < 0.01*
Transfer discussed on time (yes) 75% 79% 0.78
Education negatively influenced by the disease? 0.76
• No • 30% • 29%
• Repeating a class • 23% • 19%
• Lower level • 12% • 12%
• More absenteeism • 19% • 29%
• Other • 15% • 12%
Taking the disease into account at choice for vocation (yes) 59% 42% 0.13
Restriction in career options by the disease (yes) 48% 25% 0.96
*: p-value * < 0.05 was considered statically significant
±: VAS satisfaction with transition: score range 1–10, higher score reflects higher satisfaction
±±: score-range of OYOF-TES 18–90, higher score reflects higher satisfaction of YP with transition
± ± ±: score-range of OYOF-SES 10–64, higher score reflects higher self-efficacy of YP
Abbreviations: YP Young People, JIA Juvenile Idiopathic Arthritis, VAS visual analogue scale, OYOF-TES on your own feet transfer experience scale, OYOF-SES on
your own feet self-efficacy scale
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thought that their education was negatively influenced
by the disease (Table 3). This was seen in YP transferred
to the adult clinic as well as in YP transferred to the
adolescent JIA-clinic. In addition, around half of all YP
had taken the disease into account when choosing their
vocation. Almost half of the YP transferred to the adult
clinic and a quarter of YP transferred to the adolescent
clinic stated that they were restricted in career options
by their disease.
Discussion
The implementation of the clinical transition pathway
for YP with jRMD was successful: a low drop-out of care
rate was seen and YP were satisfied with the transitional
process in both groups. High levels on the self-efficacy
scale were reported, suggesting confidence of all YP in
this study to have achieved sufficient self-management
skills and underlining the efficacy of the clinical transi-
tion pathway.
As a primary outcome of a successful transitional
process, we evaluated the effectiveness of the clinical
transition pathway by using the drop-out of care rate.
Despite implementing transition programs, preventing
drop-out of care is challenging. Previous studies showed
drop-out frequencies between 25 and 52% after imple-
mentation of a transition program [10–13, 22]. In histor-
ical data from the electronic patient records in our
hospital, we saw a drop-out rate of 35% after transfer to
the adult clinic in 2007, one year before the implementa-
tion of our clinical transition pathway (unpublished
data). At that time, there was no transition policy and
preparation for transfer to adult care was not structur-
ally given. Although these drop-out rates cannot be
compared one-to-one, it gives an impression of the
drop-out rates before implementation of the clinical
transition pathway. The EULAR/PReS guidelines defined
drop-out of care as a quality indicator to measure good
transition [5]. We showed low frequencies of drop-out
of care (5.1 and 1.3%) in the first year after transfer to
the adult and adolescent JIA-clinic. This indicates that
the implemented clinical transition pathway can improve
attendance and adherence to follow up clinic visits and
prevent drop-out of care. This low percentage might also
be influenced by our active policy to continue care in
the same academic hospital, the expertise with adoles-
cent care and the limited travel distances in our country.
Notably, the low drop-out of care rate of YP transferred
to the adolescent JIA-clinic seems logical, as the mean
age at transfer was lower (15.2 years) and we assume
that parents are still making the clinic appointments and
are more involved in the care process. However, three
years later (mean age 18.0) years, the drop-out of care
rate was even lower and decreased to zero. Additionally,
when considering YP that transferred to the adolescent
JIA-clinic at the age of 16 years and up to 21 years, we
still found a low drop-out of care rate of 6%. Literature
showed that the implementation of a dedicated adoles-
cent clinic has shown to improve clinical outcome [23].
Our data of the adolescent JIA-clinic underline this
conclusion.
Another quality indicator according to the EULAR/
PReS recommendations on the individual outcome of
the transitional process, is satisfaction of the YP with the
transitional process [5]. In our study the overall satisfac-
tion with the transitional process was high for both
groups in our study. Another study with YP with jRMD
resulted in almost similar scores of the VAS satisfaction
after instituting a transition program [11]. Van Staa et al.
investigated satisfaction with transition programs of YP
with a broad range of chronic somatic conditions and
showed lower percentages on both scales (respectively
61.8 and 6.6) [10].
Good alignment and collaboration between the
pediatric and adult departments was seen as an import-
ant factor for higher satisfaction of YP with the transi-
tional process [10]. The presence of good coordination
between pediatric and adult health care professionals is
also recommended as an outcome for successful transi-
tion [5, 15]. According to the EULAR/PReS recommen-
dations this can be realized by direct communication
before and after transfer by combining consultations [5].
We embedded this in the clinical transition pathway.
Moreover, we evaluated the alignment between the
pediatric and adult clinic from the perspective of the YP
with the OYOF-TES. Almost all YP in both groups were
convinced there was a good collaboration between both
departments.
Self-management is an important individual outcome
for successful transition. The high score on the
self-reported self-efficacy scale assumes more responsi-
bility in the self-management skills of the YP for both
groups. Another important measured question regard-
ing self-management skills, is independent visits, mean-
ing visits of YP with care professionals without their
parents [7, 14, 15, 24]. According to a study of
Hilderson, many YP are not given the opportunity for
independent visits with the physician [25]. Previous
studies showed percentages between 46 and 59% of
independent visits for YP between 15 and 23 years [26–
28]. In our study, almost half of the YP transferred to
the adolescent JIA-clinic had independent visits. More
independent visits were reported in the group YP trans-
ferred to the adult clinic, which seemed logical because
of the older age compared to those transferred to the
adolescent JIA clinic. This was also observed in a study
with YP with JIA, where frequency of independent
visits increased with older age [17]. Notably, our histor-
ical data obtained before a clinical transition pathway
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was implemented, showed that 88% of YP between 14 and
20 years did not visit the physicians independently [6].
This suggests improved autonomy during clinic visits of
the YP and may be contributed to the implementation of
an ITP in the clinical transition pathway. Many items in
the ITP are designed to help YP develop self-management
skills and goals are set during the consultations. Indeed,
the use of an ITP in the transitional process is strongly
recommended by the EULAR/PReS recommendations for
transitional care [5, 29, 30].
An important finding was that many YP perceived lim-
itations in their education and vocation because of the
disease. This was also found in other studies, where the
time needed to finish studies tended to be longer and
absenteeism was higher [31, 32]. These limitations might
influence their future career as higher rates of un-
employment were found in JIA patients [32–37]. These
findings support the importance of vocational guidance
and discussing vocation by health professionals [38] and
should be a prominent subject in any transition plan.
This study has limitations. Paper-questionnaires were
used with a mean response rate of 50%. Using electronic
questionnaires might have led to higher response rates
and therefore could have had an influence on the results.
In addition, the number of YP discontent with the tran-
sitional process might be higher in the non-responders,
leading to bias in the questionnaire results. Indeed, al-
though the drop-out rate in the non-responder group
was still relatively low, it was higher than the group that
returned the questionnaires. The mean age of YP trans-
ferred to the dedicated adolescent JIA clinic was 15 years.
These YP are still in the midst of the transition process
and this has influenced the results of the study. Add-
itionally, the success of this study is attributed in part to
the fact that none of the patients transferred to another
institution besides the Erasmus University MC. This is
an exceptional situation and probably influences the ex-
ternal validity of this study. However, the transition
process should start at an early age (12–14 years) and
prepare young people to be ready for the actual transfer
to adult rheumatology at age 17–18 and prevent
drop-out even if transferred to another hospital. The
transition pathway can be used to instruct the adult
rheumatologist elsewhere regarding the follow up of care
for this vulnerable patient group. The transition coordin-
ator may play a role in this process as well and support
the adult rheumatologist elsewhere.
Conclusion
The implementation of the clinical transition pathway for
YP with jRMD has led to a substantial improvement of
patient care during the transitional process leading to low
drop-out rate, improved self-reported autonomy during
the clinic visit, improved perceived self-management skills
and high satisfaction of YP with the transitional process,
which are all outcomes recently proposed in the EULAR/
PreS recommendations for transitional care. This under-
lines the efficacy of the developed clinical transition
pathway.
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